| P50 | author | Marc N Gourevitch | Q40258822 |
| | Julia H Arnsten | Q89928403 |
| P2093 | author name string | Alex D Federman | |
| | Karyn K Heavner | |
| | Alain H Litwin | |
| | Karina M Berg | |
| | Hillary V Kunins | |
| P2860 | cites work | Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection | Q27860901 |
| | Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial | Q27860949 |
| | The prevalence of hepatitis C virus infection in the United States, 1999 through 2002 | Q29619974 |
| | Accuracy of perceptions of hepatitis B and C status: cross sectional investigation of opiate addicts in treatment | Q33636189 |
| | National Institutes of Health Consensus Development Conference Statement: Management of hepatitis C: 2002--June 10-12, 2002. | Q34156940 |
| | Is it justifiable to withhold treatment for hepatitis C from illicit-drug users? | Q34795087 |
| | Human immunodeficiency virus infection in intravenous drug users: a model for primary care | Q35442653 |
| | Hepatitis C virus in the setting of HIV or hepatitis B virus coinfection | Q35877926 |
| | Response to treatment of hepatitis C in individuals with a recent history of intravenous drug abuse | Q39667760 |
| | Correlates of hepatitis C virus infections among injection drug users. | Q40453200 |
| | Medical care for injection-drug users with human immunodeficiency virus infection | Q40674545 |
| | Management of hepatitis C: a national survey of gastroenterologists and hepatologists | Q41598810 |
| | Hepatitis C identification and management by family physicians | Q42995525 |
| | Current care of hepatitis C-positive patients by primary care physicians in an integrated delivery system. | Q42996690 |
| | Treatment of hepatitis C infection in injection drug users | Q43032493 |
| | Management of hepatitis C patients by primary care physicians in the USA: results of a national survey | Q43034294 |
| | Treatment of chronic hepatitis C in injecting drug users: 5 years' follow-up | Q43036403 |
| | The importance of preventing hepatitis C virus infection among injection drug users in the United States. | Q44458986 |
| | Eligibility for treatment of hepatitis C virus infection among young injection drug users in 3 US cities | Q45420303 |
| | The impact of barriers to hepatitis C virus treatment in recovering heroin users maintained on methadone | Q45423730 |
| | Medical examinations at entry to treatment for drug abuse as an opportunity to initiate care for hepatitis C virus infection | Q45497881 |
| | Primary care for patients with human immunodeficiency virus (HIV) infection in a methadone maintenance treatment program | Q45842847 |
| | Effectiveness of isoniazid chemoprophylaxis for HIV-infected drug users at high risk for active tuberculosis. | Q50653339 |
| | Provision of on-site medical care to patients with hepatitis C in drug treatment units. | Q51935850 |
| | Management of hepatitis C in active drugs users: experience of an addiction care hepatology unit. | Q52286339 |
| | Treatment of chronic hepatitis C in active drug users. | Q53479050 |
| | Age-specific seroprevalence of HIV, hepatitis B virus, and hepatitis C virus infection among injection drug users admitted to drug treatment in 6 US cities. | Q54074176 |
| | Viral infections in short-term injection drug users: the prevalence of the hepatitis C, hepatitis B, human immunodeficiency, and human T-lymphotropic viruses. | Q55240560 |
| | Cancer screening by primary care physicians: a comparison of rates obtained from physician self-report, patient survey, and chart audit | Q57758936 |
| | Fulminant Hepatitis Associated with Hepatitis A Virus Superinfection in Patients with Chronic Hepatitis C | Q60364371 |
| | Prevalence and duration of hepatitis C among injection drug users in San Francisco, Calif | Q73466642 |
| | A nationwide survey of hepatitis C services provided by drug treatment programs | Q77877328 |
| | Current practice patterns of primary care physicians in the management of patients with hepatitis C | Q78171521 |
| P433 | issue | 1 | |
| P921 | main subject | hepatitis C | Q154869 |
| P304 | page(s) | 99-105 | |
| P577 | publication date | 2007-03-26 | |
| P1433 | published in | Journal of Substance Abuse Treatment | Q15762042 |
| P1476 | title | Hepatitis C management by addiction medicine physicians: results from a national survey | |
| P478 | volume | 33 | |